Kim Kelderman serves as the Chief Executive Officer of Bio-Techne Corporation. Taking on this leadership role, he is responsible for overseeing the company's long-term strategic vision, global operations, and financial performance. As the leader of a major life sciences tools provider, he guides the corporation’s efforts in scaling its presence in protein science, diagnostic reagents, and cell therapy manufacturing tools. His executive responsibilities include managing the firm's extensive R&D pipelines, guiding the integration of recent strategic acquisitions, and ensuring that the corporation remains a critical supplier to the global pharmaceutical and biotechnology research industries. He works closely with the Board of Directors to navigate the complexities of the rapidly evolving life sciences market, maintaining the company's reputation for quality, innovation, and reliability among its international customer base of academic researchers and pharmaceutical developers.
Bio-Techne Corporation, originally founded as Techne Corporation in 1976, has a history rooted in the evolution of modern molecular biology and the demand for high-quality research tools.
Comparing the difficulty of biotechnology and engineering is inherently subjective, as both fields are intellectually demanding but require different types of cognitive approaches.
Determining whether Bio-Techne (TECH) stock is a "good buy" depends entirely on your personal investment philosophy, your risk tolerance, and your analysis of the life sciences market.
Bio-Techne’s company values are centered on driving scientific discovery through innovation, integrity, and customer-centricity.
Finding a job in the biotechnology sector is challenging but highly achievable for candidates who possess the right combination of specialized education, practical laboratory skills, and persistent networking.
Bio-Techne Corporation employs several thousand highly skilled professionals across its global operations, which include manufacturing sites, research facilities, and commercial sales offices.
Bio-Techne operates in a highly competitive life sciences tools and clinical diagnostics market, facing rivalry from other global giants that also manufacture research reagents, proteins, and analytical instrumentation.
Yes, Bio-Techne Corporation is a large, significant player in the global life sciences industry.
The biotechnology sector is well-known for offering highly competitive compensation packages, especially for roles that require specialized technical education, such as Ph.D. holders, molecular biologists, data scientists, and process engineers.
A career in biotechnology can be demanding and, at times, inherently stressful due to the high-stakes environment in which professionals operate.
Bio-Techne Corporation is headquartered in Minneapolis, Minnesota, in the United States. This central location serves as the hub for the company’s executive leadership, strategic operations, and financial administration.
The amount of math in biotechnology varies significantly depending on your role.
Bio-Techne Corporation is a publicly traded company, listed on the Nasdaq stock exchange under the ticker symbol TECH.
Bio-Techne Corporation reports significant annual revenues reflecting its position as a global leader in life sciences tools and clinical diagnostics.
Bio-Techne Corporation functions as a vital supplier and technology partner to the global life sciences and pharmaceutical research communities.
Minneapolis and the broader Twin Cities metropolitan area constitute a significant, internationally recognized hub for medical technology and biotechnology innovation.
Bio-Techne provides an extensive and highly sophisticated catalog of research products that serve as foundational tools for life science laboratories worldwide.
Biotech jobs can be highly competitive, particularly for top-tier research or specialized engineering roles at prestigious firms.
Bio-Techne Corporation is a premier manufacturer of high-quality life science research tools, reagents, and clinical diagnostic products.
No, biotech jobs are not broadly declining; in fact, the sector has demonstrated remarkable resilience and long-term secular growth driven by advances in medicine, aging global demographics, and the digital transformation of biological research.
Bio-Techne is generally perceived as a strong, stable employer within the life sciences sector, known for offering a professional work environment, competitive compensation, and a clear alignment with the mission of advancing scientific discovery.
Biotechnology and genetic engineering are closely related but represent different concepts in the scientific field.
Biotechnology is generally considered a high-paying field, particularly when compared to average national salary benchmarks in many developed nations.
The timeline to become a professional in the biotechnology field varies by the specific role.
Biotechnology is broadly categorized into four primary sectors, represented by different colors: Red, Green, White, and Blue.